Prothena Corporation plc (PRTA)

NASDAQ | Biotech | Biotechnology and drug development
Free
No email, no account, no signup.
Pulling latest news for Prothena Corporation plc…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and drug development
Market Cap
$583M
We're already tracking Prothena Corporation plc — here are the latest events we've registered

Recent News

  • On May 7, 2026, Prothena reported first quarter 2026 financial results, including a net income of $32.7 million driven by a $50 million milestone payment from Novo Nordisk for coramitug. The company also updated its 2026 cash guidance and announced a share repurchase program of up to $100 million.
Want to know how this news affects Prothena Corporation plc? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Prothena Corporation plc will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
Prothena Corporation plc (PRTA)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.